Reviv3 Closes Acquisition of Substantially All Assets of AXIL & Associated Brands.
Reviv3 Procare Company (OTCQB:RVIV) has completed the acquisition of AXIL & Associated Brands, enhancing its product portfolio in hearing protection and enhancement. CEO Jeff Toghraie emphasized that this move will broaden growth and revenue opportunities. The integration aims to leverage AXIL's expertise in operational efficiencies and innovative products. Reviv3 plans to file pro forma financial statements related to the acquisition with the SEC within two weeks, signaling commitment to transparency and strategic growth.
- Acquisition of AXIL enhances product portfolio and market reach.
- Expected to significantly broaden revenue generation capabilities.
- Integration of AXIL's expertise in operational efficiency and innovation.
- Potential difficulties in implementing cost savings and efficiency initiatives post-acquisition.
- Risks related to competition in both the hair care and audio technology markets.
- Dependence on customer concentration which may affect revenue.
“This transaction expands our product portfolio across a much wider range of industries and significantly broadens our growth and revenue generation capability,” said
Reviv3 anticipates filing the required audited and pro forma financial statements concerning the acquisition with the
About Axil
AXIL creates high-tech hearing and audio innovations to provide cutting-edge solutions for people with varied applications across many industries. AXIL designs, innovates, engineers, manufactures, markets and services specialized systems in hearing enhancement, hearing protection, wireless audio, and communication. AXIL distributes its products through direct-to-consumer eCommerce channels and local, regional, and national retail chains. AXIL serves the sporting goods market, military, federal agents, law enforcement, tactical, fitness, outdoor, industrial, sporting, and stadium events. AXIL focuses primarily on US markets, followed by
About
Forward-Looking Statements
This press release contains a number of forward-looking statements within the meaning of the federal securities laws. All statements other than statements of historical fact are forward-looking statements, including any statements related to the benefits, results, and effects of the acquisition of Axil, future financial and operating results, and Reviv3's plans, objectives, expectations (financial or otherwise) and intentions following the acquisition. These forward-looking statements and information about Reviv3's current and future prospects and its operations and financial results are based on currently available information and management's beliefs, projections, and current expectations. The statements are subject to a number of significant risks and uncertainties that could cause actual future results and financial performance to vary significantly from those anticipated in such statements.
Factors that could cause actual results to differ materially from those in the forward-looking statements include, among other things: (i) Reviv3's ability to grow net sales and adjusted EBITDA following the acquisition; (ii) Reviv3's ability to fund its operating expenses; (iii) potential difficulties or delays Reviv3 may experience in implementing its cost savings and efficiency initiatives; (iv) Reviv3's ability to compete effectively with both other hair and skincare companies and high tech hearing and audio communication companies following the acquisition; (v) the concentration of Reviv3's and Axil's customers, potentially increasing the negative impact to Reviv3 by changing purchasing or selling patterns; and (vi) changes in laws or regulations in
The use of words such as "anticipates," "expects," "intends," "plans," "confident that" and "believes," among others, generally identify forward-looking statements.
Current and potential investors are urged to consider these factors carefully in evaluating the forward-looking statements. These forward-looking statements speak only as of the date hereof. Except as required by law, Reviv3 does not assume any obligation to update or revise these forward-looking statements for any reason, even if new information becomes available in the future.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220622006017/en/
Media Relations:
Reviv3 PR Team
Tel: 888-638-8883
Email: pr@reviv3.com
www.reviv3.com
Source:
FAQ
What is the significance of Reviv3's acquisition of AXIL?
How will the acquisition of AXIL impact Reviv3's revenue?
When will Reviv3 file financial statements related to the acquisition?